{"page":{"totalFilteredElements":51},"studies":[{"active":true,"description":"Long-Term Follow-up of\nPatients Treated with Miltenyi Cell and Gene Therapies [Longsafe\n  MB-CARTSAFE\n  (M-2022-393)<div>]</div>","eudractNumber":"2022-501648-14-00","id":8725,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped1","name":"Leukämien"},{"id":"ped2","name":"Lymphome"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":"NCT06508775","phase":{"id":"ph_5","name":"Phase I/II"},"recruitmentStart":"2024-05-05T14:13:36+02:00","shortTitle":"Longsafe","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Michigan Acute Graft-versus-Host Disease International Consortium (MAGIC):<br />A Database and Biorepository<br />To prospectively collect HCT data, complications and outcomes pertinent to graft-versus-host disease from allogeneic HCT patients for future analysis<br />To prospectively collect and store blood for future analysis from allogeneic HCT patients.","eudractNumber":null,"id":1326,"indications":[{"id":"sar","name":"Sarkome"},{"id":"sar1","name":"Knochensarkome (Ewing-Sarkom, Osteosarkom etc.)"},{"id":"sar2","name":"Weichteilsarkome (Liposarkom, Leiomyosarkom, etc.)"},{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped1","name":"Leukämien"},{"id":"ped4","name":"Weitere solide Tumore"},{"id":"ped5","name":"Weitere Bluterkrankungen / weitere hämatologische Erkrankungen"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2014-10-15T10:55:32+02:00","shortTitle":"MAGIC children","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Klinische Pr&#252;fung der Phase III von CPX-351 zur Behandlung von Kindern mit Myeloischer Leuk&#228;mie mit Down-Syndrom 2018","eudractNumber":"2018-002988-25","id":8960,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped1","name":"Leukämien"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2021-02-22T12:45:46+01:00","shortTitle":"ML-DS 2018","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"<p class=\"MsoNormal\" align=\"left\">Molecular Data Generation a Clinical Follow-up within the International Molecular Neuropathology Registry<i><br /></i></p><p class=\"MsoNormal\" align=\"left\"><b><i><br /></i></b></p>","eudractNumber":null,"id":6166,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2020-11-11T12:25:41+01:00","shortTitle":"MNP Int-R","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Prospective multicenter registry for neonates, infants, children, adolescents, and adults with neuroblastic tumours.<br />","eudractNumber":null,"id":3381,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2017-01-01T09:38:52+01:00","shortTitle":"NB Registry 2016","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"<p class=\"MsoNormal\">Registry of the NHL-BFM study group for all subtypes of\nNon-Hodgkin &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; lymphoma diagnosed in\nchildren and adolescents Gesellschaft f&#252;r P&#228;diatrische\nOnkologie und H&#228;matologie (GPOH)&#160;</p>","eudractNumber":null,"id":11279,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped2","name":"Lymphome"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2025-02-24T11:39:54+01:00","shortTitle":"NHL-BFM Registry V.2024.1","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Multizentrisches Register zur Erfassung des Nasopharynxkarzinoms bei Kindern, Jugendlichen und jungen Erwachsenen","eudractNumber":null,"id":6810,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2017-08-24T13:41:02+02:00","shortTitle":"NPC-2016 Registry","therapeutical":true,"therapyLines":[]},{"active":true,"description":"Nivolumab in combination with cisplatin and 5-flurouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma","eudractNumber":"2021-006477-32","id":7476,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":"NCT06019130","phase":{"id":"ph_7","name":"Phase II"},"recruitmentStart":"2023-05-17T09:50:05+02:00","shortTitle":"NPC-Nivo","therapeutical":true,"therapyLines":[{"id":"tl_3","name":"Drittlinie"}]},{"active":true,"description":"2- and 5-year neuropsychological follow-up of young\nchildren with medulloblastoma, CNS-PNET and ependymoma treated within the prospective\nmulticenter trial HIT 2000 SKK<br /><br />Geplante Laufzeit: 01.07.2013 - 31.03.2017<br />","eudractNumber":null,"id":964,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2013-07-01T13:26:27+02:00","shortTitle":"Neuropsychological diagnostics in HIT 2000 SKK","therapeutical":false,"therapyLines":[]},{"active":true,"description":"<div>P&#228;diatrisches Register f&#252;r Stammzelltransplantationen <b>und ZellTherapie (PRSZT)</b><br /></div>","eudractNumber":null,"id":965,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2013-09-18T09:10:24+02:00","shortTitle":"PRSZT (ehemals PRST)","therapeutical":false,"therapyLines":[{"id":"tl_5","name":"N/A"}]}]}